Akèy › Skleroderm Difize › New Jersey
Etid klinik pou Skleroderm Difize nan New Jersey
3 etid pou Skleroderm Difize ap chèche patisipan nan sit nan New Jersey.
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Astera Cancer Care, East Brunswick
Ap rekriteFaz 1
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104Platform Clinical Study for Conquering Scleroderma
- Robert Wood Johnson Medical School, New Brunswick
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Hackensack
- Nkarta Investigational Site, Summit
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.